Heng Lab
330 Brookline Ave
Boston MA 02115
Bridging the gap between molecular biology and clinical utility
Our research programs are unified by a single focus: understanding breast cancer biology across the disease continuum. From identifying the earliest tissue changes to decoding the intrinsic factors governing therapeutic response, we design the tools that define the future of oncology.
Recent Publications
- Associations of circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with the expression of stromal fibroblast activation markers in benign breast tissue
- Oral contraceptive use and the expression of stromal markers in benign breast tissue
- Subtype-Specific Associations of Computational Stromal Tumor-Infiltrating Lymphocytes with Breast Cancer Outcomes
- African Green Monkey Cerebrospinal Fluid miRNome Captures Conserved miRNAs Relevant to Human Neurodegenerative Disease
- Associations of alcohol use with expression of stromal markers in benign breast biopsy samples.
- The miR-362-3p/BCLAF1 axis regulates cisplatin sensitivity and metastatic progression in triple-negative breast cancer
